No Detail Found!

Comparison between Intravenous Boluses versus Infusion of Tranexamic Acid (TXA) to Reduce Bleeding in Paediatric Cyanotic Congenital Heart Disease (CHD) Surgeries.

Author(s)
Faisal Junejo Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Mohammad Irfan Akhtar Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Mohammad Hamid Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Syed Shabbir Ahmed Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Fauzia Minai Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Muneer Amanullah Department of Anaesthesia, The Aga Khan University Hospital, Karachi, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi, Pakistan
Abstract
Objective: To compare the intravenous boluses and intravenous continuous infusion of tranexamic acid (TXA) to reduce postoperative bleeding in cyanotic congenital heart disease surgeries. Study Design: Single-blinded randomised clinical trial. Place and Duration of Study: Anaesthesia Department, The Aga Khan University Hospital, Karachi, from July 2016 to April 2017. Methodology: Sixty patients of cyanotic congenital heart disease, undergoing either palliative or corrective surgery involving cardiopulmonary bypass (CPB), were recruited. These 60 patients were divided randomly into two groups. The infusion group received intravenous infusion of TXA at 5 mg/kg/hour while the bolus group received three intravenous boluses of 10 mg/kg after induction, after going to bypass and after protamine reversal. Data was collected through predesigned proforma. There were two primary outcomes: postoperative bleeding in the first 24 hours, and chest closure time. Results: Postoperative bleeding was 13.94 (10.27-20.18) ml/kg in the first 24 hours in infusion group and 15.05 (9.0423.50) ml/kg in the bolus group. Chest closure time was 38.5 (25-45) in infusion group and 30 (20-46.25) minutes in the bolus group. There was no statistically significant and clinical difference between both groups regarding postoperative bleeding in the first 24 hours and chest closure time. Conclusion: These infusion and bolus groups had comparable postoperative bleeding and chest closure time.
Publication Details
Page(s) 180-183
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 3, Year: 2018

Request the full text from PASTIC

References
RanucciM,BaryshnikovaE,CastelvecchioS,PelisseroG, 2013.Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery,Ann Thorac Surg 96 478 -85
PetäjäJ,LundströmU,LeijalaM,PeltolaK,SiimesMA, 1995.Bleeding and use of blood products after heart operations in infants,J Thorac Cardiovasc Surg 109 524 -9
BronickiRA,HallM., 2016.Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment,Pediatr Crit Care Med 17 S272 -S8
KraftF,SchmidtC,Van AkenH,ZarbockA, 2015.Inflammatory response and extracorporeal circulation,Best Pract Res Clin Anaesthesio 29 113 -23
SpiessBD, 2013.Blood transfusion and infection after cardiac surgery,Ann Thorac Surg 95 1855 -8
TempeDK,VirmaniS., 2002.Coagulation abnormalities in patients with cyanotic congenital heart disease,J Cardiothorac Vasc Anesth 16 752 -65
LaParDJ,CrosbyIK,AilawadiG,AdN,ChoiE,SpiessBD, 2013.Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery,J Thorac Cardiovasc Surg 145 796 -804
KerK,EdwardsP,PerelP,ShakurH,RobertsI, 2012.Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis,BMJ 344 e3054 -
LinCY,ShuhaiberJH,LoyolaH,LiuH,del NidoP,DiNardoJA, 2015.The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery,PloS One 10 e0126514 -
OpotowskyAR,MokoLE,GinnsJ,RosenbaumM,GreutmannM,AboulhosnJ, 2015.Pheochromocytoma and paraganglioma in cyanotic congenital heart disease,J Clin Endocrinol Metab 100 1325 -34
ChauhanS,BisoiA,KumarN,MittalD,KaleS,KiranU, 2004.Dose comparison of tranexamic acid in pediatric cardiac surgery,Asian Cardiovasc Thorac Ann 12 121 -4
CouturierR,RubattiM,CredicoC,Louvain-QuintardV,AnerkianV,DoubineS, 2014.Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass,Blood Coagul Fibrinolysis 25 259 -65
FaraoniD,CacheuxC,Van AelbrouckC,IckxBE,BarvaisL,LevyJH, 2014.Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study,Eur J Anaesthesiol 31 491 -8
SigautS,TremeyB,OuattaraA,CouturierR,TaberletC,Grassin-DelyleS, 2014.Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass,J Am Soc Anesthesiol 120 590 -600
PasqualiSK,LiJS,HeX,JacobsML,O'BrienSM,HallM, 2012.Comparative analysis of antifibrinolytic medications in pediatric heart surgery,J Thorac Cardiovasc Surg 143 550 -7
ReidRW,ZimmermanAA,LaussenPC,MayerJE,GorlinJB,BurrowsFA, 1997.The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery,Anesth Analg 84 990 -6
SchindlerE,PhotiadisJ,SinzobahamvyaN,DöresA,AsfourB,HraskaV, 2011.Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery,Eur J Cardiothorac Surg 39 495 -9
ChauhanS,BisoiA,ModiR,GhardeP,RajeshM., 2003.Tranexamic acid in paediatric cardiac surgery,Indian J Med Res 118 86 -
GiordanoR,PalmaG,PoliV,PalumboS,RussolilloV,CioffiS, 2012.Tranexamic acid therapy in pediatric cardiac surgery: a single-center study,Ann Thorac Surg 94 1302 -6
MartinK,BreuerT,GertlerR,HapfelmeierA,SchreiberC,LangeR, 2011.Tranexamic acid versus -aminocaproic acid: efficacy and safety in paediatric cardiac surgery,Eur J Cardiothorac Surg 39 892 -7
HasegawaT,OshimaY,MaruoA,MatsuhisaH,TanakaA,NodaR, 2014.Intraoperative tranexamic acid in pediatric bloodless cardiac surgery,Asian Cardiovasc Thorac Ann 22 1039 -45
PatelJ,PrajapatiM,PatelH,GandhiH,DeodharS,PandyaH. Topical, 2017.and low-dose intravenous tranexamic acid in cyanotic cardiac surgery,Asian Cardiovasc Thorac Ann 25 118 -22
NgWCK,JerathA,WasowiczM., 2015.Tranexamic acid: a clinical review,Anaesthesiol Intensive Ther 47 339 -50
0

Citations

0

Downloads

124

Views